Cargando…
Replacement of the Trabecular Meshwork Cells—A Way Ahead in IOP Control?
Glaucoma is one of the leading causes of vision loss worldwide, characterised with irreversible optic nerve damage and progressive vision loss. Primary open-angle glaucoma (POAG) is a subset of glaucoma, characterised by normal anterior chamber angle and raised intraocular pressure (IOP). Reducing I...
Autores principales: | Fan, Xiaochen, Bilir, Emine K., Kingston, Olivia A., Oldershaw, Rachel A., Kearns, Victoria R., Willoughby, Colin E., Sheridan, Carl M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464777/ https://www.ncbi.nlm.nih.gov/pubmed/34572584 http://dx.doi.org/10.3390/biom11091371 |
Ejemplares similares
-
Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2
por: Callaghan, Breedge, et al.
Publicado: (2022) -
Exploiting biomaterial approaches to manufacture an artificial trabecular meshwork: A progress report
por: Crouch, Devon J., et al.
Publicado: (2021) -
Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
por: Fan, Yuchen, et al.
Publicado: (2020) -
An Optimized Method to Decellularize Human Trabecular Meshwork
por: Crouch, Devon J., et al.
Publicado: (2022) -
Atorvastatin reduces IOP in ocular hypertension in vivo and suppresses ECM in trabecular meshwork perhaps via FGD4
por: Song, Xiang-Yuan, et al.
Publicado: (2022)